HomePRME • NASDAQ
Prime Medicine Inc
Follow
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 1.23M | 486.12% |
Operating expense | 11.21M | -20.52% |
Net income | -50.58M | 3.69% |
Net profit margin | -4.13K | 83.57% |
Earnings per share | -0.32 | 27.27% |
EBITDA | -52.09M | 1.10% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 213.29M | 21.51% |
Total assets | 385.01M | 15.69% |
Total liabilities | 223.19M | 55.77% |
Total equity | 161.82M | — |
Shares outstanding | 177.04M | — |
Price to book | 3.86 | — |
Return on assets | -40.64% | — |
Return on capital | -58.60% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -50.58M | 3.69% |
Cash from operations | -35.04M | -35.22% |
Cash from investing | -92.12M | -282.99% |
Cash from financing | 144.75M | 275.85% |
Net change in cash | 17.59M | -72.05% |
Free cash flow | -17.48M | 75.56% |
Previous close
$3.55
Day range
$3.55 - $3.95
Year range
$1.11 - $6.94
Market cap
694.97M USD
Avg Volume
4.20M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2019
Website
Employees
214
